CTXR vs TFX · rev $7.1M vs P/E 2083, rev $1.12B
Citius Pharmaceuticals Inc (CTXR) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
Citius Pharmaceuticals Inc (CTXR) is a biotechnology company listed on US.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
Latest reported CTXR revenue for 2026-06-30 was $7.1M. Net income was -$49.4M. Revenue was up 26.6% from 2026-03-31 to 2026-06-30. CTXR currently screens at market cap $13.4M.
Latest reported TFX revenue for 2026-06-30 was $1.12B. Net income was $91.5M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
CTXR currently screens at market cap $13.4M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the CTXR and TFX stock pages for the full models.
Not investment advice.